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Abstract
The M2 protein of influenza A virus is a membrane-spanning tetrameric proton channel targeted by the
antiviral drugs amantadine and rimantadine1. Resistance to these drugs has compromised their effectiveness
against many influenza strains, including pandemic H1N1. A recent crystal structure of M2(22–46) showed
electron densities attributed to a single amantadine in the amino-terminal half of the pore2, indicating a
physical occlusion mechanism for inhibition. However, a solution NMR structure of M2(18–60) showed four
rimantadines bound to the carboxy-terminal lipid-facing surface of the helices3, suggesting an allosteric
mechanism. Here we show by solid-state NMR spectroscopy that two amantadine-binding sites exist in M2 in
phospholipid bilayers. The high-affinity site, occupied by a single amantadine, is located in the N-terminal
channel lumen, surrounded by residues mutated in amantadine-resistant viruses. Quantification of the
protein–amantadine distances resulted in a 0.3 Å-resolution structure of the high-affinity binding site. The
second, low-affinity, site was observed on the C-terminal protein surface, but only when the drug reaches high
concentrations in the bilayer. The orientation and dynamics of the drug are distinct in the two sites, as shown
by 2H NMR. These results indicate that amantadine physically occludes the M2 channel, thus paving the way
for developing new antiviral drugs against influenza viruses. The study demonstrates the ability of solid-state
NMR to elucidate small-molecule interactions with membrane proteins and determine high-resolution
structures of their complexes.
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Abstract
The M2 protein of influenza A virus is a membrane-spanning tetrameric proton channel targeted
by the antiviral drugs amantadine and rimantadine 1. Resistance to these drugs has compromised
their effectiveness against many influenza strains, including pandemic H1N1. A recent crystal
structure of M2(22-46) showed electron densities attributed to a single amantadine in the N-
terminal half of the pore 2, suggesting a physical occlusion mechanism for inhibition. However, a
solution NMR structure of M2(18-60) showed four rimantadines bound to the C-terminal lipid-
facing surface of the helices 3, suggesting an allosteric mechanism. Here we show by solid-state
NMR spectroscopy that two amantadine-binding sites exist in M2 in phospholipid bilayers. The
high-affinity site, occupied by a single amantadine, is located in the N-terminal channel lumen,
surrounded by residues mutated in amantadine-resistant viruses. Quantification of the protein –
amantadine distances resulted in a 0.3 Å-resolution structure of the high-affinity binding site. The
second, low-affinity, site was observed on the C-terminal protein surface, but only when the drug
reaches high concentrations in the bilayer. The orientation and dynamics of the drug are distinct in
the two sites, as shown by 2H NMR. These results indicate that amantadine physically occludes
the M2 channel, thus paving the way for developing new antiviral drugs against influenza viruses.
The study demonstrates the ability of solid-state NMR to elucidate small-molecule interactions
with membrane proteins and determine high-resolution structures of their complexes.
The M2 protein of influenza A viruses is a modular, multifunctional protein that plays
important roles in the acidification and uncoating of the endosome-entrapped virus and in
viral assembly and budding 1,4. Its proton-conducting activity is mediated by a single
transmembrane (TM) domain that forms a four-helix bundle, which acts as a pH-activated
proton channel. The TM domain alone is sufficient for tetramerization 5,6 and for
amantadine-sensitive proton conductivity in vesicles and cell membranes 7,8.
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The recent low pH crystal structure of micelle-solubilized M2(22-46) shows a single
molecule of amantadine (Amt) in the N-terminal pore lumen, consistent with the known
stoichiometry of binding 8 and the location of resistant mutations, including Leu 26, Val 27,
Ala 30, Ser 31, and Gly 34 9-11. However, the low-pH state of the protein is only transiently
populated in acidifying endosomes, whereas the drug first binds with higher affinity to the
protein near neutral pH 9. Thus, determining the structure of the drug-complexed M2 protein
at neutral pH is important for understanding its mechanism of inhibition. The solution NMR
structure of micelle-solubilized M2(18-60) at pH 7.5 failed to show strong nuclear
Overhauser effects (NOEs) between the drug and pore-lining residues, but it would have
been difficult to observe NOEs between the fast-relaxing pore-lining residues and unlabeled
rimantadine undergoing restricted motion in the pore. Weak NOEs were observed between
residues on the protein surface and the drug, which, however, comprised 13% of the
detergent in which the protein was dissolved (200-fold excess over protein tetramers). We
thus turned to solid-state NMR (SSNMR), which allows for investigation of the dynamics
and contacts of drug molecules bound at variable concentrations to membrane proteins in
phospholipid bilayers, which are far better mimics of biological membranes than are
micelles.
Rotational-echo double-resonance (REDOR) NMR is a powerful method to measure sub-
nanometer inter-atomic distances with up to 0.1-Å accuracy 12. The M2 peptide (residues
22-46), reconstituted into DMPC vesicles at pH 7.5 under fully tetrameric conditions 6,13,
contained uniformly 13C-labeled residues whose 13C chemical shifts were assigned from 2D
correlation spectra (Supplementary Fig. 1). Amantadine was perdeuterated, thus
enabling 13C{2H} REDOR distance measurements.
To select for the highest-affinity binding site, we first measured the REDOR spectra of Amt-
complexed M2 at an Amt/peptide molar ratio (Amt/P) of 1:4 (one drug per tetramer). At this
stoichiometric concentration, Amt binds only to the luminal site: Fig. 1a shows 13C{2H}
REDOR spectra without (S0) and with (S) multiple 2H dephasing pulses 14. The Ser31 Cα
signal is strongly dephased by the deuterons (S/S0 = 0.76 ± 0.03 at 10.1 ms), indicating that
Amt binds near Ser 31. In contrast, the Asp44 Cα signal in the peripheral site is unaffected.
A double-quantum-filtered REDOR experiment that removed all lipid signals confirmed the
lack of Asp 44 dephasing (Supplementary Fig. 2).
To search for additional, lower-affinity, binding sites, we increased the Amt concentration to
Amt/P = 4 : 4, making the drug 7% of the amphiphiles composing the bilayer, which
approaches the large excess of drug in the solution NMR experiments. Now the Asp44 Cα
signal is also dephased (S/S0 = 0.86 ± 0.02 at 10.1 ms), but to a lesser extent than Ser31 Cα
(Fig. 1b). Thus, when free amantadine is a major component of the membrane, Amt contacts
the C-terminus of the protein as in the solution NMR structure, 3 but without displacing the
drug in the luminal site. Consistently, Amt deuterons also dephased other residues in the
luminal site, particularly Val27 Cγ1 and Gly34 Cα (Fig. 1c, d), but more weakly than Ser
31. This Ser 31-proximal binding is consistent with the large chemical shift perturbation of
Ser 31 by Amt 15.
2H NMR provided exquisite details on the orientation and dynamics of amantadine, whose
unique symmetry and rigidity simplify analysis. Amantadine is a rigid amphiphile with a
polar amine and a hydrophobic adamantane centered around a 3-fold axis, ZM. Three axial
C-D bonds are parallel to ZM while twelve equatorial C-D bonds are at 70° or 110° (θPM)
from ZM (Fig. 2d). Amantadine partitions strongly into protein-free DMPC vesicles and
exhibit 2H quadrupolar splittings of 36 and 123 kHz with a 4:1 intensity ratio at 243 K (Fig.
2a). These splittings indicate fast anisotropic rotation of the molecule around ZM, which
scales the couplings from the rigid-limit value of 125 kHz by (3cos2θPM−1)/2, giving 40
Cady et al. Page 2
Nature. Author manuscript; available in PMC 2010 August 4.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
kHz for the twelve equatorial bonds and 125 kHz for the three axial bonds. Wobbling of the
ZM axis by ∼6° likely accounts for the additional motional averaging. As the temperature
increased to 303 K, the couplings decreased twofold (18 and 58 kHz) while maintaining the
same 1:3 frequency ratio and 4:1 intensity ratio. The ±0.46 scaling factor indicates Amt
rotates rapidly around the normal (n⃗) of the liquid-crystalline bilayer in addition to its own
axis, with ZM tilted by 37° or 80° from n⃗ (Fig. 2e) 16.
When a stoichiometric amount (Amt/P = 1 : 4) of protein is present, the Amt spectrum at
243 K resembles the lipid-only spectrum, but the couplings remain unchanged from 243 to
303 K across the membrane phase transition (Fig. 2b), indicating sequestration of the drug
from the lipids. The constant scaling factor (0.93) compared to pure rotation around ZM
indicates that the first equivalent of Amt rotates rapidly around n⃗ in a slightly tilted
orientation (∼13°) between ZM and n⃗ (Fig. 2d). An isotropic peak grows at high
temperature, indicating a small fraction (∼12% at 303 K) of Amt either near 54.7° from the
membrane normal or undergoing large-angle tumbling in the channel. Finally, a weak 18-
kHz splitting is observed at 303 K that matches the lipid-only coupling at this temperature.
The spectrum is consistent with a 9:1 combination of the 283 K M2-bound spectrum without
the 18-kHz splitting and the 303 K lipid-bound spectrum, suggesting that 10% of the drug
partitions into the bilayer at 303 K.
To confirm that the lumen-bound drug persists under drug excess and to probe for additional
binding sites, we measured the 2H spectra under 4-fold excess Amt over the tetramer
(corresponding to 12% of the lipid concentration). Fig. 2c shows that the spectroscopic
signatures of the lumen-bound drug persists, but the 303 K spectrum is now the 1:3
combination of the stoichiometric spectrum (Fig. 2b) and the lipid-bound spectrum (Fig. 2a).
No additional bound species was detected. Since the 4-fold symmetry of the channel
requires four peripheral sites for each luminal site, the 9:1 intensity ratio of the 303 K
stoichiometric spectrum suggests that Amt has at least a 40-fold greater affinity for the
channel lumen than the peripheral site.
These 2H NMR and distance data indicate that M2 has a single high-affinity site for
amantadine, located in the channel lumen centered at Ser 31. In this site, Amt is nearly
aligned with the channel axis, but given sufficient thermal energy a small fraction of drug is
also able to undergo nearly isotropic motion, as suggested by molecular dynamics
simulations 17,18. Excess Amt adopts a significantly tilted orientation in the membrane, with
or without the protein. The peripherally bound rimantadines in the solution NMR structure
are tilted by 80° 3, precisely one of the two possible orientations found for the lipid-
associated drug. Since the same peripheral site is detected here in the TM peptide, its
existence is independent of the protein length or the membrane environment; it is the result
of excess drugs in the micelles and lipid bilayers.
To determine the sub-angstrom resolution structure of the high-affinity binding site, we
quantified the M2-Amt distances using an alternative REDOR experiment containing
multiple 13C pulses and one 2H pulse, thus minimizing 2H pulse imperfections and yielding
REDOR intensities closely following the universal curve 19 (Supplementary Fig. 3). The
experiment yielded significantly faster REDOR dephasing (Fig. 3) while confirming the
relative dephasing of different sites in Fig. 1.
Due to the 4-fold symmetry of the tetramer, we parameterized the REDOR simulations in
terms of the distance R of each peptide carbon from the channel axis and the distance Z of
each carbon plane from the Amt center (Fig. 3c). We considered the twelve deuterons in the
two equatorial planes with rotational averaging and neglected the three axial deuterons due
to poor inversion of their broad 2H spectra. A series of REDOR curves were calculated for R
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of 2.7–6.2 Å and various Z values for each R, capturing the geometry of previous M2
structural models, (Fig. 3d-f). The curves are quite sensitive to geometry. The Ser31 Cα
pore radius is most tightly constrained, to 5.7–6.3 Å. Larger R would not give sufficient
dephasing even when Z = 0 while smaller R would shift the drug up or down the channel too
much to comply with the observed intensities of Val27 Cγ1 and Gly34 Cα. The best-fit Z
places Ser31 Cα in the middle of the two planes of deuterons.
We computed an ensemble of structures using these protein-drug distances and previous
SSNMR constraints. The structures cluster tightly with a heavy-atom root-mean-square
deviation (RMSD) of 0.3 Å (Fig. 4). The four helices are kinked at Gly 34, with the helical
axis tilted by 30° for the N-terminal segment and 19° for the C-terminal segment, consistent
with 15N SSNMR orientational constraints 20. The narrowest points of the pore lie at the N-
terminal Val 27 and C-terminal His 37/Trp 41, which are responsible for pH sensing and
proton conduction 21. Amantadine fits snugly into the N-terminal lumen, surrounded by
residues whose mutation confers resistance 9. The surrounding backbone amides and Ser31
hydroxyl group engage in intra-helical hydrogen bonding, imparting a hydrophobic
character to the site. The luminal binding indicates that M2 inhibition is by physical
occlusion, interrupting water-wires and perturbing the protonation equilibrium of His37 22.
The N-terminal location is consistent with the fact that Amt inhibits only when added to M2-
expressing cells from the outward-facing N-terminal side 9. Moreover, the V27 vestibule is
too small to permit drug dissociation without a 1–2 Å radial expansion, consistent with the
very slow association and dissociation of the drug compared to a diffusion-controlled
process 9. Finally, the drug is most likely oriented with the adamantane packed against the
hydrophobic Val27 sidechains and the polar amine towards the cavity near His 37 residues,
whose pKa's are affected by Amt binding 22.
The present SSNMR structure has significant differences from previous proposed structures
of the Amt-M2 complex 2,3. While the drug location is very similar to that of the low-pH
crystal structure, the shape of the binding site differs dramatically (3.4-Å Cα RMSD
between the structures). In the crystal structure, the helices splay far apart near the C-
terminus (Fig. 5b), to minimize electrostatic repulsions among the protonated His 37. In the
high-pH SSNMR structure, the helices close off the bottom of the site, fully sequestering the
drug and explaining the improved affinity at higher pH (Fig. 5a). The backbone of the
SSNMR structure is more similar to the high-pH solution NMR structure, with comparable
distances involving Val27 Cγ1, Ser31 Cα, and Gly34 Cα (Supplementary Fig. S5). Thus,
the drug may have been present in the lumen in the solution NMR sample but not observable
without isotopic labeling. Alternatively it might have been truly absent from the lumen due
to reduced affinity to the micelle-bound and structurally plastic protein 23-25. The current
high-resolution structure also revises an earlier SSNMR chemical-shift-constrained M2
model, where the lack of protein-drug distances resulted in a large N-terminal vestibule,
which would yield a highly solvent-accessible low-affinity drug (Supplementary Fig. S6-
S7).
What is the significance of the peripheral site? Since it is occupied only at drug/lipid or
drug/detergent ratios above 7 mol%, the protein-drug interactions at this site must be weak,
and largely a consequence of the high local concentration and preference of the drug for the
membrane-water interface 16. The peripheral site may in some way be related to the partial
inhibition of M2 by polyamines in the absence of sodium ions 26.
Since amantadine undergoes significant motion in the N-terminal lumen, its structure
appears to be not fully optimized to fit the M2 channel. Thus, other drugs may be designed
to access the most conserved regions of the pore and evade drug resistance. Indeed, a potent
and structurally distinct class of inhibitors has been recently reported that binds the same site
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27
. Solid-state NMR spectroscopy, especially the multi-deuteron 13C-2H distance strategy,
opens a new avenue for structure elucidation of drug-complexed membrane proteins in lipid
bilayers, yielding distances with longer range and higher accuracy than NOE measurements
in solution.
Methods Summary
The 13C-labeled wild-type Udorn M2(22-46) peptide was synthesized by solid-phase
methods and reconstituted into DMPC bilayers at pH 7.5 by detergent dialysis 25, giving
fully tetramerized protein in the liposomes 6. 13C{2H} REDOR experiments were conducted
on a 9.4-Tesla wide-bore NMR spectrometer (Bruker Biospin) using a 4 mm 1H/13C/2H
MAS probe. The distances were measured at 243 K, where the peptide was immobilized 28
while Amt was uniaxially mobile. Static 2H spectra were measured on a 14.1-Tesla SSNMR
spectrometer.
An ensemble of 17 lowest-energy SSNMR structures was computed using 24 (6×4) long-
range 13C-2H distances, four inter-helical distances among Trp41 indole rings 13, 60 (15×4)
backbone amide orientational constraints 20, two sidechain rotamer constraints 29, and
idealized covalent geometry. For comparison, the previous solution NMR M2 structure
ensemble was constrained by 12 inter-helical NOEs and 18 amide residual dipolar couplings
for the TM region 3. The structure ensemble has been deposited in the Protein Databank (ID:
2KQT) and the BMRB (ID: 16612).
Methods
Sample preparation
The wild-type Udorn M2(22-46) sequence SSDPLVVAASIIGILHLILWILDRL was
synthesized with 13C, 15N-labeled amino acids at Leu 26, Val 27, Ala 29 and Gly 34 in one
sample (LVAG), and Ser 31, Ile 32, and Asp 44 in another sample (SID). The peptide was
reconstituted into DMPC vesicles by detergent dialysis using octyl-β-D-glucopyranoside.
The peptide/lipid molar ratios were 1:8 for all 2H NMR experiments and 1:8 or 1:15 for the
REDOR experiments. A phosphate buffer (pH 7.5) was used for lipid vesicle preparation
and throughout detergent dialysis. The dialyzed proteoliposome solutions were centrifuged
at 150,000 g to obtain ∼40% hydrated membrane pellets. Amantadine was directly titrated
into the membrane pellet to the desired amount.
Solid-state NMR spectroscopy
A triple-resonance 1H/13C/2H magic-angle-spinning (MAS) probe was used for the 13C-2H
REDOR experiments and a 1H/13C/15N probe was used for 2D correlation experiments for
resonance assignment. The 2H pulse length in the REDOR experiments was 6.2 μs, and 13C
and 15N pulse lengths were 5-6 μs.
13C-2H REDOR experiments were carried out at MAS frequencies of 4250 Hz or 4750 Hz.
A REDOR pulse sequence containing a single selective 13C pulse and multiple
composite 2H pulses was used to obtain clear qualitative dephasing at long mixing times,
since the selective 13C pulse suppressed the 13C-13C scalar coupling and gave rise to
long 13C T2 relaxation times. However, the use of multiple 2H pulses is known to slow
down dipolar dephasing by the cumulative effects of imperfect inversion of the broad 2H
quadrupolar spectra 30. Thus, a second version of REDOR experiment consisting of
multiple 13C non-selective pulses and a single composite 2H pulse was carried out to obtain
quantitative dephasing values at shorter mixing times. Distance quantification was possible
because the multiple heteronuclear couplings commute and the uniaxial rotation of
amantadine removes the effects of 2H-2H homonuclear couplings. Perdeuteration speeded
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up 13C-2H REDOR dephasing by -fold compared to a single 13C-2H pair. The
inversion efficiency of the deuterons in the single-2H-pulse REDOR experiment was 70%
based on measurements of the model compound 13Cα, 2Hβ-labeled alanine (Supplementary
Fig. 3).
REDOR distance simulations
Using a motionally averaged model, we calculated REDOR curves for various published M2
models (Supplementary Fig. S4-6), with pore radii R of 2.7 – 6.2 Å. For each R, several
REDOR curves with different Z values were calculated. The best-fit Z values for a specific
R were compared with the carbon plane separations in the structural model. Plane
separations that are inconsistent with the differences in Z values exclude the structural
model. The Ser31 Cα pore radius is constrained by the M2-drug distances to be 5.7 – 6.3 Å.
Once amantadine is confined within 1 Å vertical distance of the Ser31 Cα plane, the Val27
Cγ1 and Gly34 Cα pore radii are jointly constrained by the Val27 Cγ1 – Gly34 Cα plane
separation, which is 10.5 ± 1.0 Å in all M2 structures so far. We found that neither RV nor
RG can exceed 6.0 Å, as it would lead to overly small plane separations.
In the final refined SSNMR structure, Val27 Cγ1 is fit by RV = 3.8 Å with ZV = −5.3 Å,
indicating that the Val27 Cγ1 plane is 5.3 Å above the center of amantadine. Gly34 Cα is fit
by RG = 4.9 Å with a distance of 5.0 Å below the amantadine center.
Structure calculation and refinement
The process of generating a helix that is consistent with the protein-drug distances,
backbone N-H orientational constraints, and sidechain rotameric conformations, was carried
out in two phases. In the first phase, we constructed an ideal helix with the sequence
SSDPLVVAASIIGILHLILWILDRL whose ϕ/ψ angles were set to (-65°, -42°). The helix
was then split at the Gly34-Ile35 bond and reconnected using a rigid-body optimization
procedure that maximized agreement with the SSNMR 15N-1H dipolar couplings 20 and the
internal geometry at that bond. Rotamer preferences were taken from the high-resolution X-
ray structure of M2 (PDB ID: 3BKD).
In the second phase we refined our model to maximize agreement with the 13C-2H REDOR
distances (Supplementary Table S2) and the backbone 15N-1H dipolar couplings
(Supplementary Table S3). To do this, we combined an inverse kinematics algorithm with a
Monte Carlo/Simulated Annealing (MC/SA) minimization procedure that would gradually
relax the backbone of the helix subject to REDOR distance constraints and the N-H dipolar
couplings. Rotamer preferences were also changed to maximize agreement with the χ1
angle constraints (Supplementary Table S4). The MC/SA minimization procedure was used
to generate an ensemble with a maximum heavy-atom RMSD of 0.3 Å between any two
models. Since the REDOR distances provided excellent constraints between the drug and
M2, we positioned the amantadine molecule near Ser 31 without the need for further
minimization. Fig. 5 was created using the PyMOL Molecular Graphics System.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Drug-protein proximities from 13C{2H} REDOR spectra of Amt-bound M2 in DMPC
bilayers at two Amt/P ratios
Control (S0), dephased (S, red), and difference (ΔS) spectra at specified mixing times are
shown. a. Ser31, Ile32, Asp44-labeled (SID) M2 at the stoichiometric ratio of Amt/P = 1 : 4.
b. SID-M2 at the 4-fold excess ratio of Amt/P = 4 : 4. Ser31 Cα is dephased under both
conditions but Asp44 Cα is dephased only when Amt is in excess. c-d. Leu26, Val27,
Ala29, and Gly34-labeled (LVAG) M2 at Amt/P = 4 : 4. c. Gly34 Cα region. d. Val27 Cγ1
region.
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Figure 2. 2H NMR spectra of d15-Amt in DMPC bilayers as a function of temperature and Amt/
P
a. No M2. The calculated spectrum for 303 K reproduces the 1:3 frequency ratio and 4:1
intensity ratio of the two splittings. b Amt/P = 1: 4. The sum spectrum reproduces the 303 K
spectrum by 1:9 combination of the lipid-bound 303 K spectrum and peptide-bound 283 K
spectrum (not shown). c. Amt/P = 4 : 4. The sum spectrum uses a 1:3 combination of the
M2-bound spectrum (II) and lipid-bound spectrum (I). d. Amt orientation in the M2 channel.
e. One of the two possible Amt orientations in the lipid bilayer.
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Figure 3. M2-Amt distance quantification
a-b. 13C{2H} REDOR spectra of Amt-bound M2 (Amt/P = 4 : 4) obtained by the single-2H-
pulse REDOR. a. SID-M2 at 4.2 ms mixing. b. LVAG-M2 at 6.1 ms mixing. c-f. REDOR
simulations. c. Definition of the pore radius R and height difference Z from the center of
Amt. d. Ser31 Cα simulation. e. Val27 Cγ1 simulation. f. Gly34 Cα simulation.
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Figure 4. SSNMR structure of Amt-bound M2 in lipid bilayers
a. Side view showing Ser 31, Val 27, Gly 34, His 37, Trp 41, and Amt in the high-affinity
luminal site. Ser31 Cα lies in the mid-plane between the two rings of deuterons. The
instantaneous orientation of Amt, which is slightly tilted from the channel axis, is shown.
The time-averaged Amt orientation is parallel to the channel axis. b Top view showing the
Ser 31 and Val 27 pore radii. This ribbon diagram was generated using the program Insight
II.
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Figure 5. Comparison of the high-pH SSNMR structure of Amt-bound M2 in lipid bilayers with
the low-pH crystal structure of Amt-bound M2
a. Side view of the high-pH SSNMR structure, showing Amt to be enclosed by Val 27 at the
top and His 37 at the bottom. b. Side view of the low-pH crystal structure 2. The helices are
splayed far apart near the C-terminus. c. C-terminal view of the high-pH structure, showing
a well-sequestered drug. d. C-terminal view of the low-pH structure, showing a more
solvent-accessible drug. The figure was generated using the program PyMOL.
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